Literature DB >> 9460495

A new serial transfer explant cell culture system for human prostatic cancer tissues preventing selection toward diploid cells.

T Zwergel1, H Kakirman, H Schorr, B Wullich, G Unteregger.   

Abstract

An improved explant cell culture technique to avoid selection of prostatic adenocarcinoma cells toward diploid cells is described. This method is based on 1) histologically characterized tissue explants, 2) the use of polyethylenteraphthalate (PET) membranes as growth surface, which are part of special inserts in six-well-plates to allow 3) cocultivation with heterologous fibroblasts, and 4) coating of the membranes with elements of the extracellular matrix. The main characteristic of this particular approach is the serial transfer of the tissue explant from one membrane to the other. Up to ten serial transfer steps could be performed to produce cell monolayers growing out of the same tissue specimen. Using this approach, 21 prostatic carcinoma specimens that were obtained from 13 primary prostatic adenocarcinomas after radical prostatectomy were cultivated. Ploidy of the cells was monitored by fluorescence in situ DNA hybridization using the centromere specific DNA probes pUC1.77, p alpha 7t1, and pY3.4. Interestingly, a high aneuploidy rate of the cell cultures was found with maintainance of aneuploidy in 18 (86%) of the 21 paraffin-embedded cancer tissue specimens with proved aneuploidy. Although a slight decrease of the proportion of aneuploid cells during serial transfer was observed, significant aneuploid cell populations were retained up to a maximum of ten transfer steps. These findings indicate that selection toward diploid cells can be prevented by improved cell culture techniques that mimic the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460495     DOI: 10.1016/s0165-4608(97)00062-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.

Authors:  B Beheshti; J Karaskova; P C Park; J A Squire; B G Beatty
Journal:  Mol Diagn       Date:  2000-03

2.  [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

Authors:  M Saar; J Kamradt; V Jung; M Stöckle; G Unteregger
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

3.  [Development of a three-dimensional primary prostate cancer cell culture model].

Authors:  V Jung; M Saar; R Grobholz; M Stöckle; G Unteregger; J Kamradt
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

4.  Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice.

Authors:  Xu Fang Pei; Marcia S Noble; Maria Antonietta Davoli; Edward Rosfjord; Maddalena T Tilli; Priscilla A Furth; Robert Russell; Michael D Johnson; Robert B Dickson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jan-Feb       Impact factor: 2.416

5.  Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.

Authors:  Henrik Suttmann; Margitta Retz; Friedrich Paulsen; Jürgen Harder; Ulrike Zwergel; Jörn Kamradt; Bernd Wullich; Gerhard Unteregger; Michael Stöckle; Jan Lehmann
Journal:  BMC Urol       Date:  2008-03-03       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.